Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Basal Cell 15Neoplasms 5Pancreatic Neoplasms 4Stomach Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Medulloblastoma 3Colorectal Neoplasms 3Basal Cell Nevus Syndrome 3Urinary Bladder Neoplasms 2Lymphoma 2Hematologic Neoplasms 2Breast Neoplasms 2Brain Neoplasms 2Adenocarcinoma 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Platinum-Resistant Fallopian Tube Carcinoma 1Pancreatic Diseases 1Odontogenic Cysts 1Neuroectodermal Tumors, Primitive 1Neoplasms, Unknown Primary 1Neoplasms, Basal Cell 1Neoplasms by Site 1

Interventions

durvalumab 5Nivolumab 3Cyclophosphamide 3Cisplatin 3130-nm albumin-bound paclitaxel 3padeliporfin 2anlotinib 2Trabectedin 2Sunitinib 2Pemetrexed 2Docetaxel 2Chemoradiotherapy 2Carboplatin 2Bevacizumab 2sotorasib 1relatlimab 1relacorilant 1pembrolizumab 1patritumab 1palbociclib 1olaparib 1niraparib 1nintedanib 1montanide ISA 51 1golotimod 1genexol-PM 1ceralasertib 1cemiplimab 1camrelizumab 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms by Site × HhAntag691 × Clear all
NCT01088815 2019-04-26

Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
98 enrolled 14 charts
Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pancreatic Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡